申请人:VALENTIA BIOPHARMA
公开号:US20160194274A1
公开(公告)日:2016-07-07
The present invention refers to phenanthrene derivatives for use as medicaments, mainly in the prevention and/or treatment of Myotonic Dystrophy Type 1, Huntington's Disease Like 2, Spinocerebellar Ataxia Type 8, Myotonic Dystrophy Type 2, Spinocerebellar Ataxia Type 3, Fragile-X-Associated Tremor/Ataxia Syndrome, Frontotemporal Degeneration/Amyotrophic Lateral Sclerosis and Spinocerebellar Ataxia Type 31. In a preferred embodiment, phenanthrene derivatives of the invention are also used as antimyotonic agents. Therefore, this invention may be included either in the whole pharmaceutical or medical field.
本发明涉及苯并并芘衍生物作为药物的用途,主要用于预防和/或治疗肌无力型1型、亨廷顿病类2型、脊髓小脑共济失调型8型、肌无力型2型、脊髓小脑共济失调型3型、脆性X相关震颤/共济失调综合征、额颞叶退行性/肌萎缩侧索硬化和脊髓小脑共济失调型31型。在一个首选实施例中,本发明的苯并并芘衍生物也用作抗肌无力剂。因此,本发明可包括在整个制药或医学领域中。